Barclays Maintains Overweight on Sprinklr, Raises Price Target to $15
Barclays analyst Raimo Lenschow maintains Sprinklr (NYSE:CXM) with a Overweight and raises the price target from $14 to $15.
What 7 Analyst Ratings Have To Say About Sprinklr
Sprinklr (NYSE:CXM) has observed the following analyst ratings within the last quarter:
53 Biggest Movers From Yesterday
Gainers
MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.
Sprinklr Shares Gain As Analysts Hail Its Q4
Analysts mostly lifted their price targets on Sprinklr Inc (NYSE:CXM) following its Q4 beat. Sprinklr clocked Q4 FY21 revenue growth of…
Morgan Stanley Maintains Equal-Weight on Sprinklr, Raises Price Target to $15
Morgan Stanley maintains Sprinklr (NYSE:CXM) with a Equal-Weight and raises the price target from $14 to $15.
11 Information Technology Stocks Moving In Wednesday’s After-Market Session
Gainers
Taoping (NASDAQ:TAOP) stock rose 8.3% to $1.44 during Wednesday's after-market session. The market value of their outstanding shares is at $22.3 million.
Earnings Scheduled For April 6, 2022
Companies Reporting Before The Bell
• Tilray (NASDAQ:TLRY) is estimated to report earnings for its third quarter.
Morgan Stanley Maintains Equal-Weight on Sprinklr, Lowers Price Target to $14
Morgan Stanley analyst Stan Zlotsky maintains Sprinklr (NYSE:CXM) with a Equal-Weight and lowers the price target from $22 to $14.